The latest developments across drug regulation, R&D, and healthcare expansion signal important shifts in the global and Indian pharmaceutical industry
The Ebola death toll in the Democratic Republic of Congo has crossed 2,000 as the country battles a rapidly spreading outbreak. The outbreak has already claimed 2,011 confirmed deaths across five provinces.
India’s MedTech industry is entering a new phase of growth as domestic manufacturing, technology innovation, global partnerships, and healthcare demand reshape the medical devices sector.
Biosafety testing is becoming increasingly important as biopharmaceutical companies develop complex biologics and advanced therapies across Asia-Pacific
Medical device industry groups are pushing back against the government's proposed regulatory framework. Eleven medtech groups have written to Union Health Minister J P Nadda seeking a separate law for medical devices.
India’s diagnostic network is expanding as healthcare companies add advanced imaging and pathology services.
Today’s pharma news highlights major drug launches, drug approvals and financial developments across respiratory care, obesity treatment and generic medicines
Cancer care continues to evolve rapidly as global and Indian pharmaceutical companies intensify efforts across drug development, partnerships, and access programs.
Samsung Bioepis has launched its aflibercept biosimilar OPUVIZ in both vial and pre-filled syringe formats, marking an entry to Europe’s eye drug market
India could become more than a market for CAR-T therapy. For Immuneel Therapeutics, it could become the base for global CAR-T growth. The Bengaluru-based biotech is building manufacturing capacity for India and future exports.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")